Blindspot Capital features Momm Diagnostics: Can We Finally Detect Preeclampsia Before It’s Too Late?
In this episode, healthcare investor and strategist Maryann Umoren Selfe is joined by Matthias Wipf, CEO of Swiss medtech company Momm Diagnostics, to examine the systemic gaps in how we identify and fund life-saving healthcare infrastructure for women. Watch
SafeBeat Awarded $2M SBIR Grant to Advance AI-based ECG Analysis for Mobile Therapeutic Monitoring of Atrial Fibrillation Patients: Clinical Study at University of California San Francisco
SafeBeat announced today it has been awarded a Direct to Phase Il Small Business Innovation Research (SBIR grant for approximately $2M from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). SafeBeat’s research team... Read More →
EvoEndo Endoscopy System Receives FDA Clearance for All Ages
EvoEndo Inc. has announced that the EvoEndo Model LE Gastroscope is now FDA-cleared for patients of all ages — from neonates to adults. Since 2022, the EvoEndo System has been the only option available for sedation-free transnasal endoscopy for pediatric... Read More →
CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) for up to $10.4 million... Read More →
Inflammatix’s TriVerity™ Test Secures NTAP Reimbursement from CMS for First-in-Class Severity Score Working in Concert with Bacterial and Viral Insights
SUNNYVALE, Calif., Aug. 4, 2025 /PRNewswire/ — Inflammatix, a leader in host-response diagnostics, today announced that its TriVerity™ Test has been granted New Technology Add-On Payment (NTAP) reimbursement by the Centers for Medicare & Medicaid Services (CMS) for fiscal year... Read More →
Founder Spotlight: Dan Clark, Co-Founder & CEO of Linear Health Sciences
In this Founder Spotlight, we talk to Dan Clark, Co-Founder and CEO of Linear Health Sciences, about the journey behind creating life-saving medical devices like the Orchid Safety Release Valve. From navigating complex regulations to the challenges of commercialization, Dan... Read More →
Cardiosense wins FDA clearance for wearable sensor
Cardiosense announced today that it received FDA 510(k) clearance for its CardioTag wearable sensor device. The company touts CardioTag as the first multimodal, wearable sensor that simultaneously captures high-fidelity electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals. It aims to... Read More →
BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
CHARLOTTESVILLE, VA – JULY 28, 2025 – RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for... Read More →
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including... Read More →
New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease Presented at the 2025 Alzheimer’s Association International Conference featuring Veravas Inc.
Developed by Veravas Inc., VeraBIND™ Tau Assay is the first blood-based test that measures pathologically active tau for the early detection of Alzheimer’s disease in both asymptomatic and symptomatic individuals AUSTIN, Texas, July 28, 2025 /PRNewswire/ — Veravas Inc., an... Read More →